Metraipolis › archive › dc_7df31fab16a7

Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors in Non-diabetic Conditions Beyond Heart Failure and Chronic Kidney Disease: Emerging Evidence, Mechanisms,… — Europe PMC PMID:41939673

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41939673
DOI
10.7759/cureus.104727
License (as archived)
solo-consultazione
Archived
2026-11-05T03:36:21.786Z
SHA-256 of the archived text
87a26a5820ab14485dda4952ac5958c2d98545cf6a6a09d73f9c2e95406c5df1
Stable URL of this page
https://metraipolis.com/documento/dc_7df31fab16a7

How to cite

Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors in Non-diabetic Conditions Beyond Heart Failure and Chronic Kidney Disease: Emerging Evidence, Mechanisms,… — Europe PMC PMID:41939673 — Europe PMC (en), https://europepmc.org/article/MED/41939673 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7df31fab16a7 (Metraipolis archive dc_7df31fab16a7, sha256 87a26a5820ab14485dda4952ac5958c2d98545cf6a6a09d73f9c2e95406c5df1)
BibTeX
@misc{dc7df31fab16a7,
  title = {Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors in Non-diabetic Conditions Beyond Heart Failure and Chronic Kidney Disease: Emerging Evidence, Mechanisms,… — Europe PMC PMID:41939673},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41939673},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7df31fab16a7; sha256 87a26a5820ab14485dda4952ac5958c2d98545cf6a6a09d73f9c2e95406c5df1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41939673. Agents can read the archived copy with the MCP tool read_document.